Skip to Content

469 (Desvenlafaxine Succinate Extended-Release 50 mg)

Pill with imprint 469 is White, Four-sided and has been identified as Desvenlafaxine Succinate Extended-Release 50 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Desvenlafaxine is used in the treatment of major depressive disorder; depression and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 469

Desvenlafaxine Succinate Extended-Release

Imprint
469
Strength
50 mg
Color
White
Size
9.00 mm
Shape
Four-sided
Availability
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
70771-1311
Inactive Ingredients
microcrystalline cellulose, hypromelloses, magnesium stearate, polyethylene glycol, silicon dioxide, stearic acid, magnesium silicate, titanium dioxide, xanthan gum

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "469"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.